A Phase 2 study to evaluate the safety and efficacy of LOU064 in patients with Sjögren’s Syndrome
An adaptive Phase 2 randomized double-blind, placebo-controlled multi-center study to evaluate the safety and efficacy of multiple LOU064 doses in patients with moderate to severe Sjögren’s Syndrome (LOUiSSe) An adaptive Phase 2 randomized double-blind, placebo-controlled multi-center study to evaluate the s ...
Product Code: LOU064 INN or Proposed INN: Aúnnoestablecido Product Code: LOU064 INN or Proposed INN: Aúnnoestablecido Product Code: LOU064 INN or Proposed INN: AúnnoestablecidoProduct Code: LOU064 INN or Proposed INN: Aúnnoestablecido Product Code: LOU064 INN or Proposed INN: ...
Novartis Farmacéutica, S.A.
NULL
Authorised-recruitment may be ongoing or finished
Female: yes Male: yes
252
Phase 2
United States;Taiwan;Spain;Switzerland;United Kingdom;Hungary;Jordan;Poland;Belgium;Australia;Denmark;Bulgaria;Germany;China United States;Taiwan;Spain;Switzerland;United Kingdom;Hungary;Jordan;Poland;Belgium;Australia;Denmar ...